The charity LifeArc has published expert advice to support work around repurposing medicines
Drug repurposing has achieved a high profile during the coronavirus pandemic with medications such as the steroid dexamethasone and rheumatoid arthritis treatment tocilizumab being used to treat patients severely ill with COVID-19.
Now, medical research charity LifeArc and law firm Pinsent Masons have published the key lessons from a March seminar aimed at supporting charities, researchers and funders researching new uses for existing medicines. Myotubular Trust were delighted to be able to support this seminar and publication, and hope that it will contribute to a changing environment for investigating and licensing repurposed medicines way beyond COVID-19.
To read the publication, either visit: https://www.lifearc.org or download a copy of the LifeArch Repurposing PDF here.
